Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

PureTech Health (LSE:PRTC) spin-out Celea appoints Paul Audhya as CMO for Phase 3 IPF programme

PureTech Health (LSE:PRTC) plc said on 29 October 2026 that Celea Therapeutics, Inc., a Boston-based company founded by PureTech and later spun off from it, has appointed Paul Audhya, MD, MBA, as Chief Medical Officer. He will be responsible for clinical development and medical …

Ankur Sharma | 30 October 2026

Why GSK (LSE:GSK) slid on the FTSE 100: weak vaccine sales overshadowed GSK's third-quarter update

Against that backdrop, a shortfall in vaccine sales carries extra weight. Even though overall sales and earnings for the quarter were better than expected, investors focused on the area where the company had disappointed. Markets often punish a miss in a flagship category, because …

Ankur Sharma | 29 October 2026

How AstraZeneca (LSE:AZN) Closes a Pharma-Heavy FTSE 100 Results Week on Friday

It has been a week in which healthcare has rarely been out of the headlines on the London market. GSK reported on Wednesday, Haleon publishes a trading statement on Thursday, and AstraZeneca (LSE:AZN) brings the sequence to a close with its third-quarter results on …

Ankur Sharma | 29 October 2026

Why GSK (LSE:GSK) Fell 4.8% Even After Beating Forecasts in the FTSE 100

Beating forecasts is usually a reliable way for a company to please the market. Wednesday 28 October 2026 showed that it is not always enough. GSK (LSE:GSK) reported third-quarter sales and earnings that came in ahead of expectations, but its shares fell 4.78%, widely …

Ankur Sharma | 29 October 2026

How a 2% Vaccines Dip Overshadowed GSK's (LSE:GSK) 15% Specialty Surge in the FTSE 100

Two numbers framed the reaction to GSK's third-quarter results on Wednesday 28 October 2026: a 15% rise in Specialty Medicines sales and a 2% fall in vaccines, both at constant exchange rates. The first was the bigger move. The second proved the more influential. …

Ankur Sharma | 29 October 2026

What GSK's (LSE:GSK) 17p Quarterly Dividend and 70p Full-Year Plan Mean for FTSE 100 Income Seekers

For many holders of FTSE 100 shares, the dividend is the main attraction, and the payout from GSK (LSE:GSK) is a natural point of focus for that audience. Its third-quarter results on Wednesday 28 October 2026 confirmed a 17p dividend for the quarter and …

Ankur Sharma | 29 October 2026

Why Did Physiomics Plc LSE:PYC Fall 10.53% in Mixed London Trading?

Physiomics Plc — LSE:PYC fell 10.53% on29 October 2026, with the shares at 0.425p after a decrease of 0.05p on the day.

Ishan Mudgal | 29 October 2026

Why Did Poolbeg Pharma Plc LSE:POLB Fall 2.26% in Mixed London Trading?

Poolbeg Pharma Plc — LSE:POLB fell 2.26% on29 October 2026, with the shares at 6.5p after a decrease of 0.15p on the day.

Ishan Mudgal | 29 October 2026

Why Did Renalytix Plc LSE:RENX Fall 1.79% in Mixed London Trading?

Renalytix Plc — LSE:RENX fell 1.79% on29 October 2026, with the shares at 5.5p after a decrease of 0.10p on the day.

Ishan Mudgal | 29 October 2026

Why Did Sareum Holdings Plc LSE:SAR Fall 4.54% in Mixed London Trading?

Sareum Holdings Plc — LSE:SAR fell 4.54% on29 October 2026, with the shares at 15.75p after a decrease of 0.75p on the day.

Ishan Mudgal | 29 October 2026
Support

Hi! How can we help you today?

Loading…